Zobrazeno 1 - 10
of 171
pro vyhledávání: '"Huiming Yu"'
Autor:
Rongxu Du, Songqing Fan, Dan Yang, Xiaobin Wang, Xia Hou, Cheng Zeng, Dan Guo, Rongrong Tian, Leilei Jiang, Xin Dong, Rong Yu, Huiming Yu, Shuchai Zhu, Jie Li, Anhui Shi
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Oesophageal squamous cell carcinoma is one of the most commonly diagnosed carcinomas in China, and postoperative radiotherapy plays an important role in improving the prognosis of patients. Carcinomas in different locations of the
Externí odkaz:
https://doaj.org/article/74323267f4184b42b36084f0846b3d21
Autor:
Jingwei Zhang, Jiayi Yu, Dan Yang, Leilei Jiang, Xin Dong, Zhiyan Liu, Rong Yu, Huiming Yu, Anhui Shi
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundCerebral radiation necrosis (RN), a severe complication of stereotactic radiotherapy (SRT), has been shown to significantly decrease patient survival time and quality of life. The purpose of this study was to analyze whether bevacizumab can
Externí odkaz:
https://doaj.org/article/21776dc5772a44c4928b7384f8cf4be0
Autor:
Lijuan Li, Dan Yang, Yanmei Min, Anyan Liao, Jing Zhao, Leilei Jiang, Xin Dong, Wei Deng, Huiming Yu, Rong Yu, Jun Zhao, Anhui Shi
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Immunotherapy has made significant advances in the treatment of extensive-stage small-cell lung cancer (ES-SCLC), but data in combination with radiotherapy are scarce. This study aims to assess the safety and efficacy of chemoimmu
Externí odkaz:
https://doaj.org/article/bc5bf049c5264a629f3efafb33841714
Autor:
Xin Dong, Wei Deng, Leilei Jiang, Dan Yang, Huiming Yu, Dongming Li, Anhui Shi, Rong Yu, Weihu Wang
Publikováno v:
Radiation Medicine and Protection, Vol 3, Iss 2, Pp 81-85 (2022)
Objective: To compare the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) for preventive or delayed treatment in neutropenia, completion rate of concurrent chemoradiotherapy and hospitalization r
Externí odkaz:
https://doaj.org/article/9ad928adad6a4bb0bdc8f93cb41c9c2a
Publikováno v:
BMC Oral Health, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Inflammatory markers can influence the postoperative prognosis and outcome of malignant tumors. However, the role of inflammatory factors in oral squamous cell carcinoma (OSCC) are still debatable. The primary objective of this in
Externí odkaz:
https://doaj.org/article/377a9c7e88f14708b35b34008b5afdf7
Autor:
Rongxu Du, Songqing Fan, Xiaobin Wang, Xia Hou, Cheng Zeng, Dan Guo, Rongrong Tian, Dan Yang, Leilei Jiang, Xin Dong, Rong Yu, Huiming Yu, Dongming Li, Shuchai Zhu, Jie Li, Anhui Shi
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Background To study lymphatic recurrence distribution after radical surgery in the real world and guide clinical tumor volume delineation for regional lymph nodes during postoperative radiotherapy for lower thoracic squamous cell esophageal
Externí odkaz:
https://doaj.org/article/894d92b36ac24fd3b2c65a1dc2dd600a
Publikováno v:
Chinese Medical Journal, Vol 135, Iss 1, Pp 92-94 (2022)
Externí odkaz:
https://doaj.org/article/29f3b07052c54ff286e906ed8030bd4f
Publikováno v:
Mathematical Biosciences and Engineering, Vol 18, Iss 2, Pp 1280-1313 (2021)
This paper proposes a general algorithm to reconstruct watertight 2-manifold 3D bone surface model from CT images based on visual hyper-spherical mapping. The reconstruction algorithm includes three main steps: two-step thresholding, initial watertig
Externí odkaz:
https://doaj.org/article/06059c011e12447f86ce860fbc40ac1a
Autor:
Dan Yang, Jianing Cui, Jun Zhao, Jing You, Rong Yu, Huiming Yu, Leilei Jiang, Dongming Li, Bo Xu, Anhui Shi
Publikováno v:
Thoracic Cancer, Vol 11, Iss 3, Pp 754-761 (2020)
Abstract Background There is no consensus on the definition or recommended radiotherapy treatment of ultracentral non‐small cell lung cancer (NSCLC). Here, we report our institution's experience in treating ultracentral lung cancer patients with st
Externí odkaz:
https://doaj.org/article/3dd06beb127b480c9a026161aba5b7d0
Autor:
Junyue Shen, Dan Yang, Mailin Chen, Leilei Jiang, Xin Dong, Dongming Li, Rong Yu, Huiming Yu, Anhui Shi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundHypofractionated radiotherapy (HypoRT) has been used to pursue an alternative treatment regimen for patients with non-small-cell lung cancer (NSCLC) who are not eligible for stereotactic ablative radiotherapy (SABR), surgery or concurrent c
Externí odkaz:
https://doaj.org/article/2a95c61b210f4983a06427981a5d4fc5